For citations:
Komarov T.N., Bagaeva N.S., Karnakova K.K., Archakova O.A., Shchelgacheva D.S., Shcherbakova V.S., Zaslavskaya K.Ya., Bely P.A., Taganov A.V., Shohin I.E. Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia). Drug development & registration. 2024;13(1):281-290. (In Russ.) https://doi.org/10.33380/2305-2066-2024-13-1-1764
Email this article 